Immuneed News

Immuneed Successfully Renews GLP Certification, Demonstrating a Strong Commitment to Quality.

2022 was a successful and eventful year for our team, and we are eager to continue building on that success in 2023.

Finalist for Innovation of the year, 2022

A bright and promising 2022 started filled with hope putting an end to the pandemic and being able to meet friends and families under more normal circumstances.

SWEDAC, has certified that Immuneed fulfills the requirements for GLP. The achievement confirms Immuneed’s longstanding focus on thoroughness and quality in preclinical testing.

In this recent podcast, we went down memory lane and got a historical insight into how it all began, but also talked about the bright future...

Introducing our CEO! On September 1st 2020, Camilla Oldgren left her position as Managing Director Nordic/Baltic at Kyowa Kirin to assume the role of Chief Executive Officer (CEO) for Immuneed.

Immuneed AB Partners with QUALIblood SA to Drive Innovation and Growth in Drug Development